School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, China.
Chongqing Key Laboratory of Green Synthesis and Applications, College of Chemistry, Chongqing Normal University, Chongqing, 401331, China.
Anal Chim Acta. 2019 May 30;1057:114-122. doi: 10.1016/j.aca.2018.12.062. Epub 2019 Jan 9.
Organic-inorganic hybrid nanomaterial has gained much attention due to its excellent performances in bioanalysis and biomedicine. However, the preparation of DNA-inorganic hybrid nanomaterial with suitable size for cell uptake remains a huge challenge. Herein, a moderate biomineralization strategy for synthesis of Y-DNA@Cu(PO) (Y-DNA@CuP) hybrid nanoflowers is reported. Y-DNA with a loop structure is used as both the biomineralization template and the recognition unit for thymidine kinase 1 (TK1) mRNA. The Y-DNA probe can linearly response to TK1 mRNA target sequence in a range from 2 nM to 150 nM with the limit of detection as low as 0.56 nM. Interestingly, the presence of Y-DNA significantly decreases the size of Cu(PO) (CuP) particles, which allows them suitable for intracellular applications as gene nanocarriers. Once inside the cells, the hybrid nanoflowers dissolve and release the Y-DNA probes. Then, the intracellular TK1 mRNA hybridizes with the loop region of Y-DNA, which dissociates the Cy3-labeled loop strand and turns on the red fluorescence. Through the real-time imaging of the intracellular TK1 mRNA, the assessment of tumor cells before and after the treatment of drugs including β-estradiol and tamoxifen is achieved.
有机-无机杂化纳米材料因其在生物分析和生物医学中的优异性能而备受关注。然而,制备适合细胞摄取的 DNA-无机杂化纳米材料仍然是一个巨大的挑战。本文报道了一种中等生物矿化策略,用于合成 Y-DNA@Cu(PO)(Y-DNA@CuP)杂化纳米花。具有环结构的 Y-DNA 既可用作生物矿化模板,也可用作胸苷激酶 1(TK1)mRNA 的识别单元。Y-DNA 探针可以在线性范围内响应 TK1 mRNA 靶序列,浓度范围从 2 nM 到 150 nM,检测限低至 0.56 nM。有趣的是,Y-DNA 的存在显著减小了 Cu(PO)(CuP)颗粒的尺寸,使其适合作为细胞内应用的基因纳米载体。一旦进入细胞,杂化纳米花就会溶解并释放出 Y-DNA 探针。然后,细胞内的 TK1 mRNA 与 Y-DNA 的环区杂交,从而使 Cy3 标记的环链解离,并开启红色荧光。通过对细胞内 TK1 mRNA 的实时成像,实现了对包括β-雌二醇和他莫昔芬在内的药物处理前后肿瘤细胞的评估。
ACS Appl Mater Interfaces. 2018-11-30
Colloids Surf B Biointerfaces. 2015-4-22
Biochim Biophys Acta Gene Regul Mech. 2017-1-14
ACS Appl Mater Interfaces. 2021-2-24
Nanoscale. 2019-9-18
J Drug Target. 2016-9
Mater Today Bio. 2025-5-21
Int J Biol Macromol. 2024-3
Front Pharmacol. 2020-1-28